ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

WINT Windtree Therapeutics Inc

5.00
-0.30 (-5.66%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Windtree Therapeutics Inc WINT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.30 -5.66% 5.00 18:58:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.38 5.02 5.38 5.065 5.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202407:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17/4/202407:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
08/4/202415:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
16/2/202416:07EDGAR2Form 8-K - Current report
14/2/202416:23EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:40EDGAR2Form PRE 14A - Other preliminary proxy statements
01/2/202416:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202407:00GLOBEWindtree Renews Agreement with Chang Gung University for..
31/1/202407:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
31/1/202407:00EDGAR2Form 8-K - Current report
31/1/202407:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
25/1/202408:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
25/1/202407:34EDGAR2Form 8-K - Current report
25/1/202407:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
22/1/202415:45EDGAR2Form 8-K - Current report
17/1/202407:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
17/1/202406:56EDGAR2Form 8-K - Current report
16/1/202415:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/1/202415:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
18/12/202307:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
16/11/202307:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
13/11/202310:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/11/202315:21EDGAR2Form 8-K - Current report
09/11/202315:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
09/11/202315:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202307:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
12/10/202306:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10/10/202306:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
03/10/202307:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
28/9/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202307:48EDGAR2Form 8-K - Current report
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
05/9/202318:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/8/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202315:15EDGAR2Form 8-K - Current report
25/8/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202307:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
16/8/202316:19EDGAR2Form 8-K - Current report
07/8/202315:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
07/8/202315:02EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock